Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Contraception and Contraceptive Drugs

Free Subscription Articles published in Gynecol Endocrinol Retrieve available abstracts of 20 articles: HTML format

Single Articles

December 2025
1. DOUXFILS J, Morimont L, Flerin N, Gaspard U, et al
   Evaluation of the safety profile of prolonged-release EE/DNG oral contraceptives: a critical appraisal.
   Gynecol Endocrinol. 2025;41:2571648.
   PubMed     Abstract available
   
   
   
2. GU M, Ruan X, Li Y, Jia C, et al
   Effect of oral contraceptive pretreatment on IVF outcomes in women with polycystic ovary syndrome using a long GnRH agonist protocol.
   Gynecol Endocrinol. 2025;41:2594876.
   PubMed     Abstract available
   
   
   
3. REGIDOR PA, Angulo A, Colli E
   Effect over coagulation and fibrinolysis parameters of a prolonged release 24 + 4 daily use regime contraceptive formulation containing 2 mg dienogest/0.02 mg ethinylestradiol.
   Gynecol Endocrinol. 2025;41:2458708.
   PubMed     Abstract available
   
   
   
4. NI MM, Yang ST, Sun JY, Wu WW, et al
   Efficacy of first-year GnRHa therapy in girls with idiopathic central precocious puberty diagnosed after age 8: a retrospective study.
   Gynecol Endocrinol. 2025;41:2500481.
   PubMed     Abstract available
   
   
   
5. VANNUCCINI S, La Torre F, Toscano F, Speciale AR, et al
   Medical treatment for adenomyosis: long term use of progestins.
   Gynecol Endocrinol. 2025;41:2511329.
   PubMed     Abstract available
   
   
   
6. GENAZZANI AR, Fidecicchi T, Arduini D, Benagiano G, et al
   Contraception today and family planning: a comprehensive review and position statement on the ethical, medical, and social dimensions of modern contraception.
   Gynecol Endocrinol. 2025;41:2543423.
   PubMed     Abstract available
   
   
   December 2024
7. COSAR A, Ozcan P, Tanoglu FB, Tok OE, et al
   Comparative effects of the antioxidant glutathione with metformin and Diane-35 on hormonal, metabolic, and inflammatory indicators in a DHEA-induced PCOS rat model.
   Gynecol Endocrinol. 2024;40:2302086.
   PubMed     Abstract available
   
   
   
8. HAN SJ, Kim H, Ku SY, Suh CS, et al
   Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome.
   Gynecol Endocrinol. 2024;40:2309349.
   PubMed     Abstract available
   
   
   
9. LA TORRE F, Vannuccini S, Toscano F, Gallucci E, et al
   Long-term treatment for endometriosis with dienogest: efficacy, side effects and tolerability.
   Gynecol Endocrinol. 2024;40:2336121.
   PubMed     Abstract available
   
   
   
10. REGIDOR PA, Colli E, Jakimiuk A
    The drospirenone only pill as a contraceptive option for breastfeeding women: First data on users' acceptability and newborn development.
    Gynecol Endocrinol. 2024;40:2382800.
    PubMed     Abstract available
    
    
    December 2023
11. FARRIS M, Arisi E, Mirjalili N, Nappi RE, et al
    Attitudes of women and pharmacists on the opportunity to obtain a progestogen-only pill over the counter - Italian outcomes.
    Gynecol Endocrinol. 2023;39:2206922.
    PubMed     Abstract available
    
    
    
12. GENAZZANI AR, Fidecicchi T, Arduini D, Giannini A, et al
    Hormonal and natural contraceptives: a review on efficacy and risks of different methods for an informed choice.
    Gynecol Endocrinol. 2023;39:2247093.
    PubMed     Abstract available
    
    
    
13. NAPPI RE, Farris M, Gallina Toschi A, Michieli R, et al
    Overcoming barriers to oral contraception in Italy an expert opinion to empower women.
    Gynecol Endocrinol. 2023;39:2254400.
    PubMed     Abstract available
    
    
    
14. PALACIOS S, Ayala G, Gonzalez G, Badilla-Apuy CL, et al
    Combined oral contraceptives: update recommendations of the Latin American contraceptive association.
    Gynecol Endocrinol. 2023;39:2271072.
    PubMed     Abstract available
    
    
    
15. QI Q, Xia Y, Luo J, Wang Y, et al
    Cocktail treatment by GnRH-antagonist, letrozole, and mifepristone for the prevention of ovarian hyperstimulation syndrome: a prospective randomized trial.
    Gynecol Endocrinol. 2023;39:2269281.
    PubMed     Abstract available
    
    
    October 2023
16. TAHARA N, Ito F, Kawamata M, Otani M, et al
    Dienogest does not augment the gene expression of adhesion molecules, MCP-1, and monocyte adherence in human endothelial cells.
    Gynecol Endocrinol. 2023;40:2270621.
    PubMed     Abstract available
    
    
    June 2023
17. PINGARRON SANTOFIMIA C, Poyo Torcal S, Lopez Verdu H, Henriquez Linares A, et al
    Evaluation of the efficacy of an antioxidant combination for the modulation of metabolic, endocrine, and clinical parameters in patients with polycystic ovary syndrome.
    Gynecol Endocrinol. 2023;39:2227277.
    PubMed     Abstract available
    
    
    May 2023
18. BOUNOUS VE, Actis S, Rosso R, Giorgi M, et al
    No-daily hormonal contraception today: general overview and application in specific clinical settings.
    Gynecol Endocrinol. 2023;39:2214626.
    PubMed     Abstract available
    
    
    
19. JI L, Jin L, Shao MJ, Hu M, et al
    Levonorgestrel-releasing intrauterine system effects on metabolic variables in PCOS.
    Gynecol Endocrinol. 2023;39:2208667.
    PubMed     Abstract available
    
    
    March 2023
20. NAPPI RE, Tiranini L, Bosoni D, Cucinella L, et al
    Women's attitudes about combined hormonal contraception (CHC) - induced menstrual bleeding changes - influence of personality traits in an Italian clinical sample.
    Gynecol Endocrinol. 2023 Mar 14:2189971. doi: 10.1080/09513590.2023.2189971.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge.